Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

BioVaxys Technology Corp. > Good news this week, expecting another update.
View:
Post by frankman on Oct 08, 2022 11:40am

Good news this week, expecting another update.

Just checking in from off the grid for a few minutes and sorry for not reading any previous posts. Sent CEO Passin a text a few days before the news releases but got no reply as I see he's been a busy boy. I reiterated with him our past conversations and congratulated him on seeing him do the Power Play interveiws. I would however expect another news update on the patented stage 3/4 cancer tumor testing. Remember if we succeed in any of the one of two vaccine canditdates, today's share price will be a mere shadow to which it will become. In our product pipeline, we still have the COVID diagnostic tool which I don't know if he's going to license or not. By the way, he did test this on himself a while back with success. We have a good future ahead.
Comment by mba123ccu on Oct 08, 2022 2:46pm
Agree with you, we should be getting another hopefully positive update soon. If the vaccine(s) prove to be successful and get FDA approval the future does look bright indeed. 
Comment by Antioch1202 on Oct 11, 2022 8:09am
Big move incoming
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities